Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
EPS for Agios Pharmaceuticals (AGIO)
EPS in 2023 (TTM): -$3.95
According to Agios Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$3.95. In 2022 the company made an earnings per share (EPS) of -$4.24 a decrease over its 2021 EPS that were of $22.24.
EPS history for Agios Pharmaceuticals from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.95 | -6.84% |
| 2022 | -$4.24 | -119.06% |
| 2021 | $22.24 | -569.2% |
| 2020 | -$4.74 | -31% |
| 2019 | -$6.87 | 13.93% |
| 2018 | -$6.03 | -10.53% |
| 2017 | -$6.74 | 33.47% |
| 2016 | -$5.05 | 61.34% |
| 2015 | -$3.13 | 98.1% |
| 2014 | -$1.58 | -4.34% |
| 2013 | -$1.65 | 12.03% |
| 2012 | -$1.47 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -147.09% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | -237.45% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -188.63% | 🇬🇧 UK |
 Xencor XNCR | -$2.14 | -45.82% | 🇺🇸 USA |
 Exelixis EXEL | $0.28 | -107.17% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -119.71% | 🇺🇸 USA |